1. An electrochemical generator for the continual supply of 213 Bi from 225 Ac for use in targeted alpha therapy applications.
- Author
-
Forrester R, Dutech G, Akin A, Fassbender ME, and Mastren T
- Subjects
- Radiochemistry instrumentation, Electrochemical Techniques, Bismuth chemistry, Radioisotopes chemistry, Alpha Particles therapeutic use, Actinium chemistry
- Abstract
Bismuth-213 is a radionuclide of interest for targeted alpha therapy and is supplied via a radiochemical generator system through the decay of
225 Ac. Radionuclide generators employ longer lived "parent" radionuclides to routinely supply shorter-lived "daughter" radionuclides. The traditional225 Ac/213 Bi radiochemical generator relies on an organic cation exchange resin where225 Ac binds to the resin and213 Bi is routinely eluted. These resins degrade when they absorb large doses of ionizing radiation (>1 × 106 Gy/mg), which has been observed when the loading activity of225 Ac exceeds 2.59*109 Bq (70 mCi). Herein we report the development of an electrochemical generator for the supply of213 Bi that has the potential to overcome this limitation. Bismuth-213 spontaneously electrodeposits onto nickel foils in 0.1 M hydrochloric acid at 70 °C. Using this method, we were able to plate an average of 73 ± 4 % of the213 Bi in solution and obtain a final213 Bi recovery of 65 ± 8 % in 0.1 M citrate pH 4.5 via reverse electrolysis using titanium as the cathode. The recovered213 Bi had an average radiochemical purity of >99.8 % and was successfully used to radiolabel DOTATATE with an average radiochemical yield of 85.1 % (not optimized)., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tara Mastren reports financial support was provided by Los Alamos National Laboratory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF